Cargando…

Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer

PURPOSE: To evaluate the oncological outcome after stereotactic body radiation therapy (SBRT) for oligometastatic hormone-sensitive prostate cancer (omHSPC) patients. MATERIALS-METHODS: In this retrospective, observational, multi-institutional study, omHSPC patients (≤5 metastases) underwent SBRT. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baron, D., Pasquier, D., Pace-Loscos, T., Vandendorpe, B, Schiappa, R., Ortholan, C., Hannoun-Levi, J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493250/ https://www.ncbi.nlm.nih.gov/pubmed/37701481 http://dx.doi.org/10.1016/j.ctro.2023.100673

Ejemplares similares

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
por: Ahmed, Kamran A., et al.
Publicado: (2013)

Rationale for Stereotactic Body Radiation Therapy in Treating Patients with Oligometastatic Hormone-Naïve Prostate Cancer
por: Bhattasali, Onita, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer: A Retrospective Multicenter Study
por: Lemoine, Pauline, et al.
Publicado: (2021)

Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
por: Franzese, Ciro, et al.
Publicado: (2018)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
por: Saad, Fred
Publicado: (2022)

The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
por: Miura, Yuji, et al.
Publicado: (2019)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease
por: Yamashita, Hideomi, et al.
Publicado: (2020)

Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer
por: Hou, Xiaorong, et al.
Publicado: (2019)

Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate Cancer
por: Brennan, Victoria, et al.
Publicado: (2021)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
por: Gerum, Sabine, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives
por: Kinj, Rémy, et al.
Publicado: (2022)

Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease
por: Reshko, Leonid B., et al.
Publicado: (2021)

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
por: Nikitas, John, et al.
Publicado: (2019)

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials
por: Quon, Harvey C., et al.
Publicado: (2016)

Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy
por: Panizza, Denis, et al.
Publicado: (2022)

Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach
por: Ricardi, Umberto, et al.
Publicado: (2016)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study
por: Kim, D. W. Nathan, et al.
Publicado: (2014)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019)

Phase I/II Study of Extreme Hypofractionated Stereotactic Body Radiation Therapy Boost to Prostate for Locally Advanced, Node-Positive and Oligometastatic Cancer
por: Narang, Kushal, et al.
Publicado: (2020)

Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer
por: Ji, Xiaoqin, et al.
Publicado: (2021)

Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer
por: Nguyen, Kevin A., et al.
Publicado: (2020)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy
por: Carrasquilla, Michael, et al.
Publicado: (2021)

Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
por: Cilla, Savino, et al.
Publicado: (2020)

A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
por: Meyer, Jeffrey J., et al.
Publicado: (2015)

Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy
por: Mbeutcha, Aurélie, et al.
Publicado: (2017)

The changing role of radiation therapy in the management of oligometastatic disease
por: Tharmalingham, H., et al.
Publicado: (2017)

Radiation therapy for oligometastatic bone disease in breast cancer
por: Katayama, Norihisa, et al.
Publicado: (2020)

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
por: Karam, Sana D, et al.
Publicado: (2013)

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
por: Phillips, Ryan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c11h1q4n7sld2eus4ck4v50tiv